NM_004208.4:c.1805A>G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_004208.4(AIFM1):c.1805A>G(p.Asn602Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00001 in 1,097,611 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004208.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AIFM1 | NM_004208.4 | c.1805A>G | p.Asn602Ser | missense_variant | Exon 16 of 16 | ENST00000287295.8 | NP_004199.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AIFM1 | ENST00000287295.8 | c.1805A>G | p.Asn602Ser | missense_variant | Exon 16 of 16 | 1 | NM_004208.4 | ENSP00000287295.3 | ||
AIFM1 | ENST00000675092.1 | c.1832A>G | p.Asn611Ser | missense_variant | Exon 16 of 16 | ENSP00000501772.1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome AF: 0.0000100 AC: 11AN: 1097611Hom.: 0 Cov.: 29 AF XY: 0.0000110 AC XY: 4AN XY: 362973
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Combined oxidative phosphorylation deficiency;CN118851:Charcot-Marie-Tooth Neuropathy X Uncertain:1
This sequence change replaces asparagine with serine at codon 602 of the AIFM1 protein (p.Asn602Ser). The asparagine residue is moderately conserved and there is a small physicochemical difference between asparagine and serine. This variant is present in population databases (rs147206884, ExAC 0.002%). This variant has not been reported in the literature in individuals with AIFM1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at